MEDIPHARMA 2019-013-GLOB1 FRESCO-2
- ORGANE :
- COMITE CGFL : DIGESTIF
- PHASE : DIGESTIF
- DATE : 2021-02-17
Médecin : Dr. GHIRINGHELLI
ARC : Céline Schoutith [3427] 03 80 73 77 51
A Global, Multicenter, Randomized, Placebo-Controlled Phase 3 Trial to Compare the Efficacy and Safety of Fruquintinib Plus Best Supportive Care to Placebo Plus Best Supportive Care in Patients with Refractory Metastatic Colorectal Cancer (FRESCO-2)